Dublin, March 07, 2017 -- Research and Markets has announced the addition of the "Revenue Recognition Accounting Update (ASC 606)" conference to their offering.
The new Revenue Recognition Standard has finally been issued. The new guidance standardizes how companies should recognize revenue under U.S. GAAP and IFRS. This conference will go through the new guidance and address the latest developments in key areas, significant changes, scope, disclosure and impacts.
Learning Objectives:
- Review the latest changes in key areas
- Understand the big picture concepts from an SEC perspective
- Begin to assess the effects of the new standard on your company or clients
Who Should Attend:
- CFOs (and their staff)
- Controllers
- VPs of Finance
- Financial Managers
- Internal Auditors
- Tax Accountants
- Treasury Staff
- Accountants in Industry
- Internal Control/SOX personnel
- Consultants
- Public Accountants
- Educators
Agenda:
Agenda: DAY 1
8:00 - 8:45 - Continental Breakfast and Registration
8:45 - 10:15 - Revenue Recognition: New Standard
- Lessons learned from the most recent amendments and EITFs
- Effective date and transition issues
- Scope of new standard and overviews
10:15 - 10:30 - Break
10:30 - 12:00 - Revenue Recognition: New Standard (continued)
- Step 1: identifying the contract
- Step 2: identifying performance obligations
- Step 3: determine the transaction price
- Step 4: allocate the transaction price
- Step 5: recognizing revenue
- other provisions and implementation guidance
12:00 - 1:00 - Lunch
1:00 - 2:30 - Revenue Recognition: Case Studies and Practical Examples
- Collectibility, Contingent Revenue, Sales to Distributors
- Performance Obligations Over Time, Elimination of VSOE for Software
- Residual Approach, Term Licenses, Time Value of Money...
2:30 - 2:45 - Break
2:45 - 4:00 - Roundtable Discussion
- Making revenue recognition manageable for those on the front lines
- Engaging in a dialogue: narrowing the gap between sales and accounting
- When and how to communicate issues of emerging importance
4:00 - 4:15 - Break
4:15 - 5:30 - Disclosure Issues
- Reconciliation of contract balances
- Extensive qualitative disclosures
- Disaggregation of revenue
- Interim period disclosures
Agenda: DAY 2
8:30 - 10:15 - ASC 606: Connecting the Dots
- Work through a comprehensive example of a transaction under ASC 606 using a simplified version of a checklist
- Fully interactive session
- Tackle the standard step by step
10:15 - 10:30 - Break
10:30 - 12:00 - Tax Impact of the New Standard
- Why does it matter
- Overview of income recognition rules
- Tips & best practices
12:00 - 1:00 - Lunch
1:00 - 2:30 - Revenue Recognition: Added Case Studies and Practical Issues
- Contract Costs
- Contract Modifications
- Warranties
- Other
2:30 - 2:45 - Break
2:45 - 4:20 - Transition Issues
- What steps to take now
- Guidance on adjustments as business models evolve (i.e. cloud computing)
- Resulting changes to sales/operations/IT/accounting policies
For more information about this conference visit http://www.researchandmarkets.com/research/pn6w8x/revenue
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Accounting


Lockheed Martin Secures $328.5 Million U.S. Defense Contract for Advanced Systems Supporting Taiwan Air Force
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration
Vietnam’s EV Taxi Giant GSM Eyes Hong Kong IPO With $2–3 Billion Valuation
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube
Neuralink Plans Automated Brain Implant Surgeries and Mass Production by 2026
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
BP’s Castrol Stake Sale Raises Debt Relief Hopes but Sparks Cash Flow Concerns
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026 



